11/11/2015 - 12:14pm

One of the appealing aspects of artificial lashes is that looks can be changed with moods.

11/11/2015 - 12:14pm

Lead by incredible 60% growth in the brow segment, the eye category has been a bright spot for mass market retailers.

11/11/2015 - 12:14pm

Shoppers hear, “It may help prevent diarrhea,” so they make the purchase. What they seldom understand is that probiotics are much more than just a diarrhea preventive. In fact, probiotics can be found in the ears, nose, mouth, lungs, urinary tract and more, and are linked to overall health, not just gastrointestinal health.

11/11/2015 - 12:14pm

Skyn Condoms, a brand of Ansell Healthcare, is partnering with the Movember Foundation this month with a special “Movember Edition box.” Drug Store News spoke with Carol Carrozza, Ansell VP sales and marketing at TSE. Here’s what she had to say.

11/11/2015 - 12:13pm

Birth rates are on the rise, according to the latest report from the Centers for Disease Control and Prevention. That’s good news for sellers of family planning test kits — overall sales of both pregnancy and ovulation test kits were up 2.2% to $364.8 million across total U.S. multi-outlets for the 52 weeks ended Sept. 6, according to IRI.

11/11/2015 - 12:13pm

A new, dynamic diabetes-centric set co-created by Johnson & Johnson and Wakefern has the potential to generate $1,000 in incremental dollars for every new diabetes customer captured by Wakerfern’s ShopRite stores, the companies revealed recently at the GMDC Health Beauty Wellness 2015 conference in Phoenix.

11/11/2015 - 12:13pm

Valeant Pharmaceuticals’ decision to raise the prices on a handful of drugs it has acquired over the past few years has led federal lawmakers and the Department of Justice to demand that the company explain its pricing policy.

11/11/2015 - 12:13pm

A merger frenzy has hit the generics sector this year with a spate of acquisitions and hostile-takeover bids making headlines and reshaping the industry.

11/11/2015 - 12:13pm

As 2015 draws to a close, the year is on track to be one in which the value of the branded drugs losing their patent protection approaches an all-time high. The dozens of drugs that will have lost their patent protection this year are estimated to have global sales of $44 billion a year — the highest total since $53 billion worth of medications went off patent in 2012.